SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure

Author:

Li Huilong,Wan Luming,Liu Muyi,Ma Enhao,Huang Linfei,Yang Yilong,Li Qihong,Fang Yi,Li Jingfei,Han Bingqing,Zhang Chang,Sun Lijuan,Hou Xufeng,Li Haiyang,Sun Mingyu,Qian Sichong,Duan Xuejing,Zhao Ruzhou,Yang Xiaopan,Chen Yi,Wu Shipo,Zhang Xuhui,Zhang Yanhong,Cheng Gong,Chen Gengye,Gao Qi,Xu Junjie,Hou Lihua,Wei Congwen,Zhong HuiORCID

Abstract

SARS-CoV-2 spike protein (SARS-2-S) induced cell–cell fusion in uninfected cells may occur in long COVID-19 syndrome, as circulating SARS-2-S or extracellular vesicles containing SARS-2-S (S-EVs) were found to be prevalent in post-acute sequelae of COVID-19 (PASC) for up to 12 months after diagnosis. Although isolated recombinant SARS-2-S protein has been shown to increase the SASP in senescent ACE2-expressing cells, the direct linkage of SARS-2-S syncytia with senescence in the absence of virus infection and the degree to which SARS-2-S syncytia affect pathology in the setting of cardiac dysfunction are unknown. Here, we found that the senescent outcome of SARS-2-S induced syncytia exacerbated heart failure progression. We first demonstrated that syncytium formation in cells expressing SARS-2-S delivered by DNA plasmid or LNP-mRNA exhibits a senescence-like phenotype. Extracellular vesicles containing SARS-2-S (S-EVs) also confer a potent ability to form senescent syncytia without de novo synthesis of SARS-2-S. However, it is important to note that currently approved COVID-19 mRNA vaccines do not induce syncytium formation or cellular senescence. Mechanistically, SARS-2-S syncytia provoke the formation of functional MAVS aggregates, which regulate the senescence fate of SARS-2-S syncytia by TNFα. We further demonstrate that senescent SARS-2-S syncytia exhibit shrinked morphology, leading to the activation of WNK1 and impaired cardiac metabolism. In pre-existing heart failure mice, the WNK1 inhibitor WNK463, anti-syncytial drug niclosamide, and senolytic dasatinib protect the heart from exacerbated heart failure triggered by SARS-2-S. Our findings thus suggest a potential mechanism for COVID-19-mediated cardiac pathology and recommend the application of WNK1 inhibitor for therapy especially in individuals with post-acute sequelae of COVID-19.

Funder

Development Program of China grant

National Natural Science Foundation of China

Publisher

Public Library of Science (PLoS)

Reference56 articles.

1. The COVID-19 epidemic and total mortality: missed data and the incoming epidemiology];E Paci;Epidemiol Prev,2023

2. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC);ZA Sherif;Elife,2023

3. Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management;B Munipalli;SN Compr Clin Med,2022

4. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms;AD Proal;Front Microbiol,2021

5. COVID-19 and the heart;A Xanthopoulos;World J Clin Cases,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3